Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 6:05 pm Purchase | 13G | NEUROGENE INC NGNE | EcoR1 Capital LLC | 1,282,168 9.99% | 1,282,168 (New Position) | View |
| 2024-02-14 4:37 pm Purchase | 13G | NEUROGENE INC NGNE | GREAT POINT PARTNERS LLC | 994,229 7.75% | 25,000 (+2.58%) | View |
| 2024-02-14 4:26 pm Sale | 13G | NEUROGENE INC NGNE | Redmile Group LLC | 1,050,304 8.1% | -232,357 (-18.12%) | View |
| 2024-02-14 4:16 pm Purchase | 13G | NEUROGENE INC NGNE | Samsara BioCapital L.P. | 1,282,563 9.99% | 1,282,563 (New Position) | View |
| 2024-02-14 3:08 pm Purchase | 13G | NEUROGENE INC NGNE | Cormorant Asset Management LP | 746,180 5.82% | 746,180 (New Position) | View |
| 2024-02-14 2:02 pm Purchase | 13G | NEUROGENE INC NGNE | JANUS HENDERSON GROUP PLC JHG | 841,688 6.6% | 841,688 (New Position) | View |
| 2024-02-14 09:19 am Sale | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Lynx1 Capital Management LP | 46 0.1% | -2,291,087 (-100.00%) | View |
| 2023-12-27 4:03 pm Purchase | 13G | NEUROGENE INC NGNE | GREAT POINT PARTNERS LLC | 969,229 7.56% | 969,229 (New Position) | View |
| 2023-12-22 4:15 pm Purchase | 13G | NEUROGENE INC NGNE | Redmile Group LLC | 1,282,661 9.9% | 1,282,661 (New Position) | View |
| 2023-12-21 4:05 pm Purchase | 13D | NEUROGENE INC NGNE | McMinn Rachel | 1,273,351 9.9% | 1,273,351 (New Position) | View |
| 2023-12-20 5:24 pm Purchase | 13D | NEUROGENE INC NGNE | BAKER BROS. ADVISORS LP | 649,685 4.99% | 649,685 (New Position) | View |
| 2023-10-10 4:42 pm Purchase | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 1,894,669 19.99% | 1,894,669 (New Position) | View |
| 2023-08-17 5:12 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 9,472,098 19.99% | -570,979 (-5.69%) | View |
| 2023-07-27 5:15 pm Sale | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | Redmile Group LLC | 2,912,228 6.6% | -118,338 (-3.90%) | View |
| 2023-07-19 5:28 pm Purchase | 13D | NEOLEUKIN THERAPEUTICS INC NLTX | BAKER BROS. ADVISORS LP | 10,043,077 19.99% | 5,813,250 (+137.43%) | View |
| 2023-02-14 4:21 pm Sale | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Redmile Group LLC | 3,030,566 6.9% | -1,290,994 (-29.87%) | View |
| 2023-02-03 11:56 am Sale | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | PICTET ASSET MANAGEMENT SA | 0 0% | -2,574,289 (Position Closed) | View |
| 2023-01-19 4:10 pm Sale | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | MILLENNIUM MANAGEMENT LLC | 1,587,267 3.7% | -545,319 (-25.57%) | View |
| 2022-12-30 4:29 pm Purchase | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | Lynx1 Capital Management LP | 2,291,133 5.38% | 2,291,133 (New Position) | View |
| 2022-07-19 4:08 pm Purchase | 13G | NEOLEUKIN THERAPEUTICS INC NLTX | MILLENNIUM MANAGEMENT LLC | 2,132,586 5% | 21,165 (+1.00%) | View |